Global Proton Pump Inhibitors Market is Expected to be Worth US$ 2.9 Billion, Growing at a CAGR of 4.30% Over The Forecast Period (2020-2027) in 2020

-
Proton Pump Inhibitors
Proton Pump Inhibitors

Proton pump inhibitors are drugs that are used to reduce stomach acid levels for a long time in people who have gastroesophageal reflux disease, hyperacidity, or ulcers. In acidic environments, Proton Pump Inhibitors Market are given in an inactive form that is lipophilic in nature and readily crosses cell membranes into intracellular compartments like the parietal cell canaliculus. The inactive drug is protonated and rearranged into its active form, which irreversibly blocks the gastric proton pump of the gastric parietal cells.

Obesity is becoming more common in adults and adolescents, leading to a variety of gastroesophageal reflux disease complications such as Barret's oesophagus (BE), esophageal erosions, and esophageal adenocarcinoma. According to a 2017 report published by the US National Library of Medicine, people with a higher BMI have a higher risk of gastrointestinal diseases like gastroesophageal reflux disease, which can lead to esophageal erosions.

Furthermore, factors such as the rising prevalence of gastrointestinal diseases like duodenal ulcers, barrets oesophagus, and non-erosive reflux disease (NERD) are expected to propel the Global Proton Pump Inhibitors Market forward. In the United States, more than 60% of people have non-erosive reflux disease (NERD), and 30% of people have barrets oesophagus, according to a report published by the National Library of Medicine in July 2020.

COVID-19 has three main effects on tin: directly affecting production and demand, causing distribution channel disruptions, and having a financial impact on firms and financial markets. Due to nationwide lockdowns, supply chains and manufacturing activities in India, China, and the United States have been disrupted. While countries such as Saudi Arabia, the United Arab Emirates, Egypt, and others face difficulties in transporting drugs from one location to another.

Furthermore, people who take proton pump inhibitors for a longer period of time are more likely to contract COVID-19 infections. Proton pump inhibitors can increase the risk of COVID-19, according to a National Library of Medicine report published in August 2020. Furthermore, people who take proton pump inhibitors twice a day are more likely to contract COVID-19. These factors are limiting the global Proton Pump Inhibitors Market growth. As a result, the COVID-19 pandemic has had a negative impact on the global market for proton pump inhibitors.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

-
Image
Security Robot Market The Global Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Security robots are rapidly gaining traction due to their ability to enhance security and surveillance in various industries. These robots offer advantages such as round-the-clock monitoring, real-time video monitoring, and quick response to potential threats. The increasing need for advanced security measures to prevent theft, vandalism, and unauthorized access is driving the demand for security robots. These robots are widely used in industries such as retail, healthcare, transportation, and manufacturing to ensure the safety of assets and individuals. The market is expected to witness significant growth due to the rising security concerns and advancements in robotic technologies. Market Key Trends: One ke
Read more

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f
Read more

Smart Light or Lightning Control Market Estimated to Reach US$ 21.03 Billion by 2023

-
Image
Smart Light or Lighting Control Market Market Overview: The global Smart Light or Lighting Control Market is estimated to be valued at US$ 21.03 billion in 2023 and is expected to exhibit a CAGR of 22.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Smart light or lightning control systems enable users to control and monitor the lighting fixtures remotely to improve energy efficiency and convenience. These systems offer advantages such as reduced energy consumption, improved security, customizable lighting solutions, and enhanced ambiance. The growing need for energy-efficient lighting solutions, especially in commercial buildings, residential spaces, and industrial sectors, is driving the demand for smart light or lightning control systems. Market Key Trends: One key trend observed in the Smart Light or Lightning Control Market is the increasing integration of artificial intelligence (AI) and Internet of Things (IoT) te
Read more